2022
DOI: 10.3390/pathogens11060653
|View full text |Cite
|
Sign up to set email alerts
|

Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum

Abstract: Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidiosis. However, its efficacy in immunocompromised people such as those with AIDS, in malnourished children, or those with concomitant cryptosporidiosis is limited. In the absence of effective drugs against cryptospor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…Consequently, there is a critical need for novel effective medications [28,29] . Consequently, Octaarginine proved to improve NTZ efficacy as an anti-cryptosporidial therapeutic [30] . In the current investigation, experimental mice infected with Cryptosporidium were treated for the first time with Antinal and Septrin, either alone or added to Cu-BTC.…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, there is a critical need for novel effective medications [28,29] . Consequently, Octaarginine proved to improve NTZ efficacy as an anti-cryptosporidial therapeutic [30] . In the current investigation, experimental mice infected with Cryptosporidium were treated for the first time with Antinal and Septrin, either alone or added to Cu-BTC.…”
Section: Discussionmentioning
confidence: 99%
“…However, the coupling of the peptide octarginine and the antibiotic nitazoxanide showed excellent results, lowering the IC 50 value to 2.9 nM compared to the IC 50 of nitozoanide alone, which was 197 nM. Of all the peptides evaluated, this combination showed the best results [ 86 ].…”
Section: Peptides Active Against Apicomplexan Parasitesmentioning
confidence: 99%
“…In animals, azithromycin, nitazoxanide, paromomycin, halofuginone lactate, tylosin, and decoquinate are some active substances that may be partially effective (Shahiduzzaman and Daugschies 2012 ; Yasa Duru et al 2013 ; Yagci et al 2017 ). Considering the limited efficacy of the agents used for both humans and animals, their failure in eradication, and their toxic effects, there is an urgent need for new, effective, and safe anticryptosporidial agents (Nguyen-Ho-Bao et al 2022 ; Su et al 2022 ).…”
Section: Introductionmentioning
confidence: 99%